Wuhan Chinese Moxibustion Technology Dev. Co., Ltd. – FDA Inspection, May 26, 2017

Record Details

This FDA Inspection record concerns Wuhan Chinese Moxibustion Technology Dev. Co., Ltd., with an inspection on May 26, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: Wuhan Chinese Moxibustion Technology Dev. Co., Ltd.
Inspection Date: May 26, 2017
Product Type: Drugs
Office: Center for Drug Evaluation and Research
Person: Alice S. Tsao (FDA Associated Person)

View Company Profile

ID · 2d55ab1e-c745-4edd-8e3e-c49143a6430e

Inspection Facts

Official Action Indicated (OAI)

Significant objectionable conditions were found and regulatory or administrative action is recommended.

Inspection number: 1016658
FDA center: Human Drugs
Project area: Drug Quality Assurance
Outcome: Form 483 issued

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Wuhan Chinese Moxibustion Technology Dev. Co., Ltd.

FDA Inspection

Wuhan Chinese Moxibustion Technology Dev. Co., Ltd.May 26, 2017